ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

BYOUNG YANG M.D.

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,546Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 247

$501K Total Retail Price of All Prescriptions

Rank: 40 out of 247

397 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 397 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 397 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 5,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
OMEPRAZOLE 252 196 1 4
LISINOPRIL 197 158 2 2
FUROSEMIDE 185 160 3 5
SIMVASTATIN 180 155 4 1
PANTOPRAZOLE SODIUM 174 154 5 19
METOPROLOL TARTRATE 169 152 6 7
LEVOTHYROXINE SODIUM 165 148 7 3
WARFARIN SODIUM 128 128 8 13
AMLODIPINE BESYLATE 125 115 9 6
METFORMIN HCL 114 96 10 12
ADVAIR DISKUS 95 87 11 18
HYDROCHLOROTHIAZIDE 94 94 12 9
TRAZODONE HCL 92 83 13 28
METOPROLOL SUCCINATE 86 73 14 14
CITALOPRAM HBR 84 81 15 20
SPIRIVA 84 73 15 26
ATENOLOL 84 74 15 10
LOSARTAN POTASSIUM 82 78 18 15
PAROXETINE HCL 77 53 19 45
LIDODERM 75 69 20 74
JANTOVEN 71 71 21 76
ATORVASTATIN CALCIUM 70 63 22 8
LOVASTATIN 66 60 23 22
RANITIDINE HCL 65 45 24 34
CRESTOR 61 43 25 30
PRAVASTATIN SODIUM 56 46 26 23
TRAMADOL HCL 55 46 27 25
MIRTAZAPINE 54 43 28 46
FLUTICASONE PROPIONATE 53 43 29 37
ALENDRONATE SODIUM 53 53 29 32
SERTRALINE HCL 53 47 29 16
NAMENDA 52 52 32 47
ALLOPURINOL 52 41 32 33
SINGULAIR 51 44 34 109
PREDNISONE 50 39 35 21
CARVEDILOL 50 39 35 59
ISOSORBIDE MONONITRATE ER 50 50 35 40
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.